These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 17588391)

  • 1. Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis.
    Colli A; Campodonico R; Gherli T
    Ann Thorac Surg; 2007 Jul; 84(1):87-91. PubMed ID: 17588391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
    Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
    Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
    Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
    Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
    Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid in the treatment of Gram-positive prosthetic joint infections.
    Bassetti M; Vitale F; Melica G; Righi E; Di Biagio A; Molfetta L; Pipino F; Cruciani M; Bassetti D
    J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
    Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
    Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early experience with linezolid for infections in orthopaedics.
    Harwood PJ; Talbot C; Dimoutsos M; Sunderland G; Shaw D; Wilcox MH; Giannoudis PV
    Injury; 2006 Sep; 37(9):818-26. PubMed ID: 16620816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
    Menzin J; Marton JP; Meyers JL; Carson RT; Rothermel CD; Friedman M
    Am J Infect Control; 2010 Feb; 38(1):44-9. PubMed ID: 19762120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE; Erstad BL; Nix DE
    Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.